/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Ensho Therapeutics

Ensho Therapeutics

United States

Ensho Therapeutics is advancing a potential oral therapy to treat patients with inflammatory bowel disease (IBD).

Healthcare & Biotech

Ensho Therapeutics, based in United States, has 2 investors on file, among them Avego and Global BioAccess Fund. Its latest round on record is Series A, 2 Oct 2026, of 2 rounds. Its site was last checked 6 Nov 2026: site answers.

enshorx.com

Funding

2 rounds on record
Latest roundSeries A2 Oct 2026
Since that round1 monthno later round on record
Time between rounds1 year 1 monthon average, over 2 rounds
Oct 2026Series AInvestors not named
Sept 2025DebtInvestors not named

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
AvegoPortfolio pageVenture capital
Global BioAccess FundPortfolio pageVenture capital

More from Avego

25 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

Alveus TherapeuticsAlveus Therapeutics develops treatments for obesity and weight loss ma…Antios TherapeuticsAntios Therapeutics develops innovative therapies to treat and cure he…Aro BiotherapeuticsAro Biotherapeutics is a biotechnology company pioneering the developm…Caribou BiosciencesCaribou Biosciences is a clinical-stage biopharmaceutical company focu…CellCentricCellCentric develops a drug called inobrodib for the treatment of mult…

See Avego's full profile · Who invests alongside it

More from Global BioAccess Fund

10 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

Acesion PharmaAcesion Pharma aims to develop more efficacious and safe drugs for the…Altay TherapeuticsAltay Therapeutics develops small molecules to address serious disease…Alveus TherapeuticsAlveus Therapeutics develops treatments for obesity and weight loss ma…Cartography BiosciencesCartography Biosciences is developing molecules that are lethal to can…EpsilogenEpsilogen is a company that discovers and develops immunoglobulin IgE,…

See Global BioAccess Fund's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Ensho Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Avego adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/enshorx.com/investors

# also
GET /v1/companies/enshorx.com
GET /v1/companies/enshorx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing